HIF stabilizing agents: Shotgun or scalpel?

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 3, 2007, Pages

  Asikainen, Tiina M ^a   White, Carl W ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; STABILIZING AGENT; VASCULOTROPIN RECEPTOR;

EDITORIAL; GENE EXPRESSION; GESTATION PERIOD; HUMAN; HYPOPLASIA; HYPOXIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; COBALT; DEFEROXAMINE; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; LUNG; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PREMATURE BIRTH; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;

EID: 34548426035     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00251.2007     Document Type: Editorial

References (12)

1. Asikainen TM, Chang LY, Coalson JJ, Schneider BK, Waleh NS, Ikegami M, Shannon JM, Winter VT, Grubb P, Clyman RI, Yoder BA, Crapo JD, White CW. Improved lung growth and function through hypoxia-inducible factor in primate chronic lung disease of prematurity. FASEB J 20: 1698-1700, 2006.
2. Burri PH. Structural aspects of postnatal lung development-alveolar formation and growth. Biol Neonate 89: 313-322, 2006.
3. deLemos RA, Roberts RJ, Coalson JJ, deLemos JA, Null DM, Gerstmann DR. Toxic effects associated with the administration of deferoxamine in the premature baboon with hyaline membrane disease. Am J Dis Child 144: 915-919, 1990.
4. Gardner PR, Raineri I, Epstein LB, White CW. Superoxide radical and iron modulate aconitase activity in mammalian cells. Biochem J 270: 13399-13405, 1995.
5. Groenman FA, Rutter M, Wang J, Caniggia I, Tibboel D, Post M. Effect of chemical stabilizers of hypoxia-inducible factors on early lung development. Am J Physiol Lung Cell Mol Physiol (June 1, 2007). doi:10.1152/ajplung.00486.2006.
6. Grover TR, Asikainen TM, Kinsella JP, Abman SH, White CW. Hypoxia-inducible factors HIF-1α and HIF-2α are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. Am J Physiol Lung Cell Mol Physiol 292: L1345-L1351, 2007.
7. Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278: 30772-30780, 2003.
8. Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2: 177-185, 2006.
9. Papandreou I, Cairns RA, Fontna L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3: 187-197, 2006.
10. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, Nizet V. Cutting edge: essential role of hypoxia-inducible factor-1α in development of lipopolysaccharide-induced sepsis. J Immunol 178: 7516-7519, 2007.
11. Thébaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175: 978-985, 2007.
12. Van Tuyl M, Liu J, Wang J, Kuliszewski M, Tibboel D, Post M. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am J Physiol Lung Cell Mol Physiol 288: L167-L178, 2005.